Pathology Asia Holdings is a medical diagnostics company focused on providing quality diagnostic services across Southeast Asia and beyond. The company aims to enhance patient outcomes by supporting clinical decision-making through a range of services. These include clinical diagnostic services, alcohol and other drugs advisory services, and clinical-grade genetic testing and genomics services tailored for translational research. By leveraging the expertise of both medical professionals and corporate experts, Pathology Asia strives to make affordable and reliable diagnostic solutions accessible to a broad patient population.
Bluestar Genomics is a company that delivers epigenomic and big data approaches to reinvent non-invasive molecular diagnostic testing.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.